RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+0.65%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,360
Reduced
1,565
Closed
46
Top Buys
| 1 |
Moderna
MRNA
|
+$63.3M |
| 2 |
Analog Devices
ADI
|
+$46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.7M |
| 4 |
Match Group
MTCH
|
+$29M |
| 5 |
Tesla
TSLA
|
+$20.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$86.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$77.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$76.7M |
| 4 |
Apple
AAPL
|
+$74M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$67.8M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Financials | 14.19% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCF
1801
DELISTED
Chase Corporation
CCF
| $2.39M | ﹤0.01% |
23,390
+3,096
| +15% | +$316K |
|
1802
SpartanNash
SPTN
$897M
| $2.39M | ﹤0.01% |
109,047
-13,573
| -11% | -$297K |
|
|
RVNC
1803
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.38M | ﹤0.01% |
85,476
+3,013
| +4% | +$83.9K |
|
1804
Verra Mobility
VRRM
$3.92B
| $2.38M | ﹤0.01% |
157,727
+4,727
| +3% | +$71.2K |
|
1805
CEVA Inc
CEVA
$564M
| $2.37M | ﹤0.01% |
55,601
-8,280
| -13% | -$353K |
|
1806
Heidrick & Struggles
HSII
$1.03B
| $2.37M | ﹤0.01% |
53,158
-7,196
| -12% | -$321K |
|
|
DNB
1807
DELISTED
Dun & Bradstreet
DNB
| $2.37M | ﹤0.01% |
140,960
-10,748
| -7% | -$181K |
|
|
PRSU
1808
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $2.37M | ﹤0.01% |
52,172
-7,840
| -13% | -$356K |
|
|
TGH
1809
DELISTED
Textainer Group Holdings limited
TGH
| $2.37M | ﹤0.01% |
67,799
+2,052
| +3% | +$71.6K |
|
1810
Repay Holdings
RPAY
$507M
| $2.36M | ﹤0.01% |
102,447
+8,880
| +9% | +$204K |
|
1811
Travere Therapeutics
TVTX
$2.09B
| $2.36M | ﹤0.01% |
97,241
+3,009
| +3% | +$73K |
|
1812
AppFolio
APPF
$9.9B
| $2.36M | ﹤0.01% |
19,573
+652
| +3% | +$78.5K |
|
1813
Super Micro Computer
SMCI
$26.7B
| $2.36M | ﹤0.01% |
644,200
+16,350
| +3% | +$59.8K |
|
1814
Expro
XPRO
$1.43B
| $2.36M | ﹤0.01% |
133,515
+101,525
| +317% | +$1.79M |
|
1815
AdaptHealth
AHCO
$1.26B
| $2.35M | ﹤0.01% |
100,909
-3,486
| -3% | -$81.2K |
|
1816
Allogene Therapeutics
ALLO
$251M
| $2.33M | ﹤0.01% |
90,768
+2,938
| +3% | +$75.5K |
|
1817
American Well
AMWL
$107M
| $2.33M | ﹤0.01% |
12,793
-150
| -1% | -$27.3K |
|
1818
Vroom, Inc. Common Stock
VRM
$137M
| $2.33M | ﹤0.01% |
1,319
-43
| -3% | -$75.9K |
|
1819
Playtika
PLTK
$1.41B
| $2.33M | ﹤0.01% |
84,250
+13,312
| +19% | +$368K |
|
|
NXGN
1820
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.33M | ﹤0.01% |
165,044
-18,607
| -10% | -$262K |
|
|
TRIL
1821
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.33M | ﹤0.01% |
132,421
+4,038
| +3% | +$70.9K |
|
1822
Harmonic Inc
HLIT
$1.13B
| $2.32M | ﹤0.01% |
265,331
-37,028
| -12% | -$324K |
|
1823
Riot Platforms
RIOT
$5.87B
| $2.32M | ﹤0.01% |
90,343
-2,621
| -3% | -$67.4K |
|
1824
Simulations Plus
SLP
$303M
| $2.31M | ﹤0.01% |
58,547
+10,218
| +21% | +$404K |
|
1825
Zentalis Pharmaceuticals
ZNTL
$107M
| $2.31M | ﹤0.01% |
34,666
+2,776
| +9% | +$185K |
|